Physician profile
Ornob Roy
NPI 1891908430
$16,946.24
in general payments reported to CMS, 2019-2025
10 companies · $369 in 2025
The $369 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,712 · 2020: $1,920 · 2021: $1,355 · 2022: $2,535 · 2023: $594 · 2024: $1,461 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,618 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $800 · Education: $5.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,618.48 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $800.00 |
| Education | $5.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $13,525.21 | 2019-2024 | |
| Boston Scientific Corporation | $1,451.66 | 2019-2025 | Lithovue, General - Erectile Dysfunction, General - Kidney Stone Disease |
| Urogen Pharma, INC. | $1,051.93 | 2021-2025 | Jelmyto |
| Ethicon US, LLC | $244.69 | 2020-2022 | |
| Biom'Up France Sas | $209.46 | 2021 | |
| Olympus America INC. | $195.27 | 2019-2024 | Itind System |
| Neotract INC. | $132.14 | 2019 | |
| Intuitive Surgical, INC. | $96.66 | 2023-2025 | Da Vinci Surgical System |
| Covidien LP | $30.87 | 2019 | |
| Histosonics, INC. | $8.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ornob Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.